Physician

Anastasia Traband, MD

According to 2025 Medicare claims, Anastasia Traband, MD (NPI: 1851686331) practices ophthalmology in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is EYE CONSULTANTS OF PENNSYLVANIA, PC (NPI: 1033181904; TIN: 231876291) and primary practice location at 19610-1992.

Traband's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 904 traditional Medicare patients, billed 29,804 HCPCS/CPT codes, and received $3,009,384 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 971 prescription claims across 263 beneficiaries totaling $64,388 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 36 records totaling $954. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $59,477 to $3,009,384. Similarly, Part D prescription costs have risen steadily, from $22,056 to $64,388. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2017 Medicare payment: $59,477 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $859,172 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,573,006 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,325,572 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,220,024 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,160,435 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,138,895 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,009,384 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017182513$59,477
20186805,453$859,172
20197267,755$1,573,006
20201,10711,341$2,325,572
202195214,819$3,220,024
202287114,604$3,160,435
202385028,879$3,138,895
202490429,804$3,009,384

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$53K$105K2015 Drug cost: $22,056 (USD; Tot_Drug_Cst)2016 Drug cost: $9,001 (USD; Tot_Drug_Cst)2017 Drug cost: $7,520 (USD; Tot_Drug_Cst)2018 Drug cost: $44,839 (USD; Tot_Drug_Cst)2019 Drug cost: $60,826 (USD; Tot_Drug_Cst)2020 Drug cost: $51,118 (USD; Tot_Drug_Cst)2021 Drug cost: $105,363 (USD; Tot_Drug_Cst)2022 Drug cost: $81,278 (USD; Tot_Drug_Cst)2023 Drug cost: $75,597 (USD; Tot_Drug_Cst)2024 Drug cost: $64,388 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201596382$22,056
2016100212$9,001
201785178$7,520
2018125443$44,839
2019167579$60,826
2020195636$51,118
2021229913$105,363
2022212797$81,278
2023213812$75,597
2024263971$64,388

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2202,704$658
67028Injection of drug into eye3821,993$88
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more531811$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more328796$58
92134Imaging of retina8652,850$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost16960$7,692
DifluprednateDifluprednate611,744$6,967
Prednisolone AcetatePrednisolone Acetate1776,395$6,432
ProlensaBromfenac Sodium15442$5,214
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol221,450$4,695

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$954Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Anastasia Traband, MD?

Tedicare shows public-source Medicare data for Anastasia Traband, MD (NPI 1851686331), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anastasia Traband, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anastasia Traband, MD?

Anastasia Traband, MD is linked to EYE CONSULTANTS OF PENNSYLVANIA, PC (billing NPI 1033181904) in the available physician profile data.

Does Anastasia Traband, MD have Open Payments data?

Anastasia Traband, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.